Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo

Overview of attention for article published in Science Immunology, February 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 11 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 56 X users
patent: 2 patents

Readers on

mendeley: 127 Mendeley

So far, Altmetric has seen 16 news stories from 11 outlets.

Rare T Cells Fight Cancer

The Scientist Magazine, 01 May 2017

T-CELL TARGET: Metastatic melanoma, pictured here, has been in the sights of immunotherapy developers.

Fred Hutch scientists to cover advances in immunotherapy, proteomics at AACR

Health Medicinet, 29 Mar 2017

Scientists from the Fred Hutchinson Cancer Research Center in Seattle are scheduled to present and discuss the latest…

Fred Hutch Scientists to Cover Advances in Immunotherapy, Proteomics at AACR

Newswise, 29 Mar 2017

Return to Article List Next Article > Article ID: 672088 Released: 29-Mar-2017 2:05 PM EDT Source Newsroom: Fred Hutchinson…

Fred Hutch scientists to cover advances in immunotherapy, proteomics at AACR

EurekAlert!, 29 Mar 2017

Scientists from the Fred Hutchinson Cancer Research Center in Seattle are scheduled to present and discuss the latest…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 12 additional news stories.